Combination Therapies and Personalized Medicine
Mismatch Repair
Cancer Prevention
Cancer-Critical Genes I: Proto-oncogenes
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 14, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Caitlin G Allen1, Colleen Donahue2, Emma Coen1
1Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina.
A new clinical management strategy was developed to improve care for individuals with hereditary cancer risks. This approach addresses challenges in managing pathogenic variants and enhances guideline adherence for high-risk patients.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: